Ads
related to: after retinal detachment surgery timeline- About Biosimilars
Review Important Info. View
Full Prescribing & Safety Info
- Dosing Information
Find PAVBLU™ Dosing And
Administration Info.
- Clinical Studies
Review Clinical Study
Results for PAVBLU™.
- Clinical Safety Results
Review Safety & Efficacy
Information For PAVBLU™.
- Important Safety Info
Find Important Safety Information
For PAVBLU™.
- Help Get Patients Started
See Dosing & Administration Info
For PAVBLU™.
- About Biosimilars
Search results
Results From The WOW.Com Content Network
Retinal detachment is a condition where the retina pulls away from the tissue underneath it. [1] [2] [3] It may start in a small area, but without quick treatment, it can spread across the entire retina, leading to serious vision loss and possibly blindness. [4] Retinal detachment is a medical emergency that requires surgery. [2] [3]
Proliferative vitreoretinopathy (PVR) is a disease that develops as a complication of rhegmatogenous retinal detachment.PVR occurs in about 8–10% of patients undergoing primary retinal detachment surgery and prevents the successful surgical repair of rhegmatogenous retinal detachment.
A scleral buckle is one of several ophthalmologic procedures that can be used to repair a retinal detachment. Retinal detachments are usually caused by retinal tears, and a scleral buckle can be used to close the retinal break, both for acute and chronic retinal detachments. [citation needed] Scleral buckles come in many shapes and sizes.
The risk of retinal detachment is the greatest in the first 6 weeks following a vitreous detachment, but can occur over 3 months after the event.. The risk of retinal tears and detachment associated with vitreous detachment is higher in patients with myopic retinal degeneration, lattice degeneration, and a familial or personal history of previous retinal tears/detachment.
Surgically correct retinal detachment by scleral buckle or pars plana vitrectomy. [1] Prior to surgery, oral or topical anti glaucoma drugs may be used to reduce IOP. [1] After surgical correction of the retinal detachment, the condition resolves, aqueous cells disappear and IOP normalizes. [3] The condition is not responsive to corticosteroid ...
Recently, central serous chorioretinopathy has been understood to be part of the pachychoroid spectrum. [5] [6] In pachychoroid spectrum disorders, of which CSR represents stage II, the choroid, the highly vascularized layer below the retina, is thickened and congested with increased blood vessel diameter, especially in the deep choroid (the so-called Haller's layer).
This is referred to as an "exoplant". Placement of the scleral buckle for patients who have had a retinal detachment has been shown to lead to reattachment approximately 80 to 90 percent of the time after one surgery. In cases of failure, most patients are treated with vitrectomy.
Jules Gonin (10 August 1870 – May 1935) was a professor of ophthalmology in Lausanne who pioneered the procedure of ignipuncture, the first successful surgery for the treatment of retinal detachments. [1] [3]